Company Valuation: IntegraGen

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020
Market Cap 1 6.536 13.61
Change - 108.2%
Enterprise Value (EV) 1 4.017 10.5
Change - 161.33%
P/E -23x -36.6x
PBR 2.61x 6.28x
PEG - -1.3x
Capitalization / Revenue 0.79x 1.51x
EV / Revenue 0.49x 1.17x
EV / EBITDA -37.6x -375x
EV / EBIT -11.1x -41.2x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 -0.0439 -0.0559
Distribution rate - -
Net sales 1 8.28 9
EBITDA 1 -0.107 -0.028
EBIT 1 -0.3631 -0.255
Net income 1 -0.2848 -0.375
Net Debt 1 -2.519 -3.109
Reference price 2 1.0100 2.0500
Nbr of stocks (in thousands) 6,471 6,638
Announcement Date 03/04/20 11/06/21
1EUR in Million2EUR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 455K
21.73x7.77x15.6x1.37% 74.69B
30.56x8.79x27.4x0.04% 58.81B
33.6x6.04x18.08x0.96% 48.45B
-20.7x214.73x-22.18x-.--% 42.84B
33.49x3.25x14.04x-.--% 42.79B
48.17x5.48x30.1x-.--% 41.25B
27.6x7.84x20.39x0.41% 31.13B
35.01x7.5x19.48x-.--% 30.28B
-14.91x5.52x-6.94x-.--% 24.05B
Average 21.62x 29.66x 12.89x 0.31% 39.43B
Weighted average by Cap. 23.19x 29.31x 14.21x 0.42%

Y-o-Y evolution of P/E

Valuation ratios - P/E - IntegraGen

Historical PBR trend

Valuation ratios - PBR - IntegraGen

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - IntegraGen

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - IntegraGen